Childhood Hepatocellular Carcinoma - 12 Studies Found
Not yet recruiting |
: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors :
|
Recruiting |
: Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery :
|
Active, not recruiting |
: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery :
|
Completed |
: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer :
: |
Completed |
: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment :
: 2004-09-07 : Drug: oxaliplatin Given IV Other Names: |
Withdrawn |
: Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer : Liver Cancer : 2009-05-09 :
|
Withdrawn |
: Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery : Liver Cancer : 2007-05-08 :
|
Withdrawn |
: Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer : Liver Cancer : 2006-01-12 :
|
Recruiting |
: Collecting and Storing Tissue From Young Patients With Cancer : Cancer : 2009-05-09 :
|
Completed |
: Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor : Cancer : 2005-09-08 : Biological: therapeutic allogeneic lymphocytes The total CD3+ cell dose target is 1.8 x 108 CD3+ cells/k |